238 related articles for article (PubMed ID: 16372299)
1. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.
Andersson I; Lundkvist A; Haller O; Mirazimi A
J Med Virol; 2006 Feb; 78(2):216-22. PubMed ID: 16372299
[TBL] [Abstract][Full Text] [Related]
2. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.
Andersson I; Karlberg H; Mousavi-Jazi M; Martínez-Sobrido L; Weber F; Mirazimi A
J Med Virol; 2008 Aug; 80(8):1397-404. PubMed ID: 18551619
[TBL] [Abstract][Full Text] [Related]
3. The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey.
Ozdarendeli A; Canakoğlu N; Berber E; Aydin K; Tonbak S; Ertek M; Buzgan T; Bolat Y; Aktaş M; Kalkan A
Virus Res; 2010 Feb; 147(2):288-93. PubMed ID: 19941917
[TBL] [Abstract][Full Text] [Related]
4. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.
Simon M; Falk KI; Lundkvist A; Mirazimi A
Virus Res; 2006 Sep; 120(1-2):184-90. PubMed ID: 16632039
[TBL] [Abstract][Full Text] [Related]
5. Crimean-Congo hemorrhagic fever.
Whitehouse CA
Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
[TBL] [Abstract][Full Text] [Related]
6. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.
Andersson I; Bladh L; Mousavi-Jazi M; Magnusson KE; Lundkvist A; Haller O; Mirazimi A
J Virol; 2004 Apr; 78(8):4323-9. PubMed ID: 15047845
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.
Bordi L; Lalle E; Caglioti C; Travaglini D; Lapa D; Marsella P; Quartu S; Kis Z; Arien KK; Huemer HP; Meschi S; Ippolito G; Di Caro A; Capobianchi MR; Castilletti C
PLoS One; 2015; 10(2):e0116816. PubMed ID: 25693189
[TBL] [Abstract][Full Text] [Related]
8. Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
Mild M; Simon M; Albert J; Mirazimi A
J Gen Virol; 2010 Jan; 91(Pt 1):199-207. PubMed ID: 19812264
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of Crimean-congo hemorrhagic fever virus in Iran.
Chinikar S; Persson SM; Johansson M; Bladh L; Goya M; Houshmand B; Mirazimi A; Plyusnin A; Lundkvist A; Nilsson M
J Med Virol; 2004 Jul; 73(3):404-11. PubMed ID: 15170636
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia.
Kuhn JH; Seregin SV; Morzunov SP; Petrova ID; Vyshemirskii OI; Lvov DK; Tyunnikov GI; Gutorov VV; Netesov SV; Petrov VS
Arch Virol; 2004 Nov; 149(11):2199-213. PubMed ID: 15503207
[TBL] [Abstract][Full Text] [Related]
12. In situ rolling circle amplification detection of Crimean Congo hemorrhagic fever virus (CCHFV) complementary and viral RNA.
Andersson C; Henriksson S; Magnusson KE; Nilsson M; Mirazimi A
Virology; 2012 May; 426(2):87-92. PubMed ID: 22341783
[TBL] [Abstract][Full Text] [Related]
13. Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells.
Andersson I; Simon M; Lundkvist A; Nilsson M; Holmström A; Elgh F; Mirazimi A
J Med Virol; 2004 Jan; 72(1):83-93. PubMed ID: 14635015
[TBL] [Abstract][Full Text] [Related]
14. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus.
Garrison AR; Alakbarova S; Kulesh DA; Shezmukhamedova D; Khodjaev S; Endy TP; Paragas J
Am J Trop Med Hyg; 2007 Sep; 77(3):514-20. PubMed ID: 17827370
[TBL] [Abstract][Full Text] [Related]
15. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells.
Peyrefitte CN; Perret M; Garcia S; Rodrigues R; Bagnaud A; Lacote S; Crance JM; Vernet G; Garin D; Bouloy M; Paranhos-Baccalà G
J Gen Virol; 2010 Jan; 91(Pt 1):189-98. PubMed ID: 19812268
[TBL] [Abstract][Full Text] [Related]
16. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells.
Connolly-Andersen AM; Douagi I; Kraus AA; Mirazimi A
Virology; 2009 Aug; 390(2):157-62. PubMed ID: 19570561
[TBL] [Abstract][Full Text] [Related]
17. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR.
Yapar M; Aydogan H; Pahsa A; Besirbellioglu BA; Bodur H; Basustaoglu AC; Guney C; Avci IY; Sener K; Setteh MH; Kubar A
Jpn J Infect Dis; 2005 Dec; 58(6):358-62. PubMed ID: 16377867
[TBL] [Abstract][Full Text] [Related]
18. Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans.
Duh D; Saksida A; Petrovec M; Dedushaj I; Avsic-Zupanc T
J Virol Methods; 2006 May; 133(2):175-9. PubMed ID: 16343650
[TBL] [Abstract][Full Text] [Related]
19. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.
Bereczky S; Lindegren G; Karlberg H; Akerström S; Klingström J; Mirazimi A
J Gen Virol; 2010 Jun; 91(Pt 6):1473-7. PubMed ID: 20164263
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Crimean-Congo Hemorrhagic Fever virus.
Anagnostou V; Papa A
Infect Genet Evol; 2009 Sep; 9(5):948-54. PubMed ID: 19560561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
